Companies
Companies
J&J Invests $2bn in Game-Changing Cancer Treatments
🔍 Johnson & Johnson acquires Ambrx for $2bn to boost its ADC pipeline and advance innovative cancer treatments. 💼🌐💉
Merck Acquiring Harpoon for $680M: Revolutionizing Cancer Treatment!
📰 Merck buys Harpoon Therapeutics for $680m, boosting its cancer treatment capabilities. 💊💉 Exciting move in immuno-oncology! 🌟👨🔬🚀
Revolutionary RSV Treatment Approved in China!
📝 AZ's Beyfortus authorized as first RSV treatment in China! 💊🇨🇳 Significant breakthrough in biotech industry. 👏😃
Novartis Acquires Immunology Specialist in $425M Deal
📰 Novartis AG to buy immunology specialist Calypso Biotech BV for $425 million. 💉 Acquisition includes potential autoimmune treatment CALY-002. 🧪 Exciting developments in celiac disease and eosinophilic esophagitis research.
Shocking FDA Investigation: Obesity Drugs Linked to Suicidal Thoughts
📢 FDA investigates suicide risk of obesity drugs semaglutide and tirzepatide, as well as hair loss and aspiration during surgery. Novo Nordisk and Eli Lilly cooperate.
Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments
📣 Boehringer Ingelheim partners with Kyowa Kirin Co., Ltd. for €410m license deal to treat fibro-inflammatory diseases! 🧪💰
miRNA Specialist Resalis Therapeutics Raises €10m for Groundbreaking Obesity Treatment
💰 Italian biotech Resalis Therapeutics raises €10m in Series A funding for obesity treatment RES-010. 🍔💪📈
Goldman Sachs Raises $650 Million for Life Sciences Investments: A Game-Changer for Medical Innovations
🏦 Goldman Sachs raises $650m for life sciences investments, showing growing interest in the sector. 💼🔬💰
Oligo Factory Achieves GMP Compliance: Exceptional Quality Control and Regulatory Standards
📢 Oligo Factory achieves GMP compliance! 🏭 CEO Chris Boggess celebrates the team's hard work in maintaining high-quality standards. 💼💯
Big Moves in Biotech: Veranova Beam and AAX
📰 Exciting changes ahead in the global biotech industry! Veranova, Beam, and AAX Biotech announce top-level team shuffles. Stay tuned! 🌍💼🔬
